Close Menu

Attending scientific meetings might be a crapshoot -- they're expensive and time consuming -- but good meetings are definitely worth the resources, says DrugMonkey. Meetings are valuable for the scientific exchange that goes on, and really good ones get you "absolutely fired up about your science," he says. "When you get back to the lab, do you tear around like a wackaloon, getting new experiments and collaborations going? Then you had a GoodMeeting."

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.

Canadian regulators are beginning to share information from new drug studies, Undark reports.

Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.

In a column at the Dallas Morning News, the Stanley Medical Research Institute's E. Fuller Torrey says the Human Genome Project hasn't delivered on promised results.